Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis
- PMID: 9153291
- PMCID: PMC508088
- DOI: 10.1172/JCI119431
Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis
Abstract
Normal glomerular capillaries filter plasma through a basement membrane (GBM) rich in alpha3(IV), alpha4(IV), and alpha5(IV) chains of type IV collagen. We now show that these latter isoforms are absent biochemically from the glomeruli in patients with X-linked Alport syndrome (XAS). Their GBM instead retain a fetal distribution of alpha1(IV) and alpha2(IV) isoforms because they fail to developmentally switch their alpha-chain use. The anomalous persistence of these fetal isoforms of type IV collagen in the GBM in XAS also confers an unexpected increase in susceptibility to proteolytic attack by collagenases and cathepsins. The incorporation of cysteine-rich alpha3(IV), alpha4(IV), and alpha5(IV) chains into specialized basement membranes like the GBM may have normally evolved to protectively enhance their resistance to proteolytic degradation at the site of glomerular filtration. The relative absence of these potentially protective collagen IV isoforms in GBM from XAS may explain the progressive basement membrane splitting and increased damage as these kidneys deteriorate.
Similar articles
-
Laminin-1 reexpression in Alport mouse glomerular basement membranes.Kidney Int. 2003 Mar;63(3):826-34. doi: 10.1046/j.1523-1755.2003.00800.x. Kidney Int. 2003. PMID: 12631063
-
Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.Am J Pathol. 2000 Jun;156(6):1901-10. doi: 10.1016/S0002-9440(10)65063-8. Am J Pathol. 2000. PMID: 10854213 Free PMC article.
-
Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.J Am Soc Nephrol. 2007 Sep;18(9):2465-72. doi: 10.1681/ASN.2007030328. Epub 2007 Aug 15. J Am Soc Nephrol. 2007. PMID: 17699809
-
[Molecular genetics of Alport syndrome].Nihon Rinsho. 1992 Dec;50(12):3021-6. Nihon Rinsho. 1992. PMID: 1491454 Review. Japanese.
-
Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.Matrix Biol. 2017 Jan;57-58:45-54. doi: 10.1016/j.matbio.2016.08.005. Epub 2016 Aug 27. Matrix Biol. 2017. PMID: 27576055 Free PMC article. Review.
Cited by
-
Familial hematurias: what we know and what we don't.Pediatr Nephrol. 2005 Aug;20(8):1027-35. doi: 10.1007/s00467-005-1859-z. Epub 2005 Apr 27. Pediatr Nephrol. 2005. PMID: 15856317 Review.
-
Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.Am J Pathol. 2000 Jul;157(1):303-11. doi: 10.1016/S0002-9440(10)64541-5. Am J Pathol. 2000. PMID: 10880400 Free PMC article.
-
Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment.J Physiol. 2014 Sep 15;592(18):4013-23. doi: 10.1113/jphysiol.2014.274449. Epub 2014 Aug 8. J Physiol. 2014. PMID: 25107927 Free PMC article. Review.
-
Identification of unique α4 chain structure and conserved antiangiogenic activity of α3NC1 type IV collagen in zebrafish.Dev Dyn. 2023 Jul;252(7):1046-1060. doi: 10.1002/dvdy.590. Epub 2023 Apr 17. Dev Dyn. 2023. PMID: 37002899 Free PMC article.
-
STOX1 deficiency is associated with renin-mediated gestational hypertension and placental defects.JCI Insight. 2021 Jan 25;6(2):e141588. doi: 10.1172/jci.insight.141588. JCI Insight. 2021. PMID: 33301424 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources